23rd American Pharma & Biotech Project, Program and Portfolio Conference

16–18 Oct 2024 | Boston, Massachusetts, United States

Richard Bayney

President & Founder

Project & Portfolio Value Creation

Washington Crossing, United States

6 profile visitsSpeakerSpeaker

About me

My organisation

Project & Portfolio Value Creation

Domain Expertise – Project & Portfolio Management | Portfolio Selection by Optimization and Prioritization | Decision Analysis | Decision-making Under Risk & Uncertainty | Risk Analysis & Risk Management | Asset Valuation & Options Analysis | Strategic Planning | Licensing & Business Development | Drug Discovery & Development | Training and Facilitation.

Service offerings:

  • Training & facilitation in Project, Program, Portfolio, Resource, & Risk Management; Decision Analysis; Decision-making under risk and uncertainty; Project Leadership; Earned Value Management.

  • Client services in portfolio selection using optimization & prioritization methodologies; scenario, strategic, business, & portfolio planning; company valuation & licensing deal structures; New Product Development (NPD) and Stage Gate Review (SGR) processes; Earned Value Management; Capability Maturity Model (CMM) diagnostics in Project, Program, & Portfolio Management as well as the PMO.

  • Quantifiable client benefits include: ~15% annual increase in top and bottom line financial performance; increase in risk-adjusted NPV (ENPV), per project, by >10%; increase in option value, per project, by ~10%; reduced SGR meetings by >20%.

Social media

Speaker sessions (2)

Wednesday, 16 October 2024

09:30 - 10:00

KEYNOTE: Competing for resources at therapeutic area level to maximize enterprise portfolio value

Format:In-personLocation:Beacon Hill Ballroom
  • Improved Decision Making